SGLT2 inhibition mitigates transition from acute kidney injury to chronic kidney disease by suppressing ferroptosisYutaro Hirashima, Takanari Kitazono|Scientific Reports|2024Cited by 17
SGLT2阻害薬はフェロトーシスの抑制を介して急性腎障害から慢性腎臓病への移行を軽減する。Yutaro Hirashima|Institutional Repositories DataBase (IRDB)|2025Cited by 0